Epidermal keratin 5 expression and distribution is under dermal influence

Pigment Cell Melanoma Res. 2020 May;33(3):435-445. doi: 10.1111/pcmr.12844. Epub 2019 Nov 26.

Abstract

Human skin melanin pigmentation is regulated by systemic and local factors. According to the type of melanin produced by melanocytes, the transfer and degradation of melanosomes differ, thus accounting for most variations between ethnicities. We made the surprising observation that in a drastically changed environment, white and black phenotypes are reversible since Caucasian skin grafted onto nude mice can become black with all black phenotypic characteristics. Black xenografts differed essentially from other grafts by the levels of epidermal FGF-2 and keratin 5. In vitro analysis confirmed that FGF-2 directly regulates keratin 5. Interestingly, this phenomenon may be involved in human pathology. Keratin 5 mutations in Dowling-Degos Disease (DDD) have already been associated with the pheomelanosome-eumelanosome transition. In a DDD patient, keratin 5 was expressed in the basal and spinous layers, as observed in black xenografts. Furthermore, in a common age-related hyperpigmentation disorder like senile lentigo (SL), keratin 5 distribution is also altered. In conclusion, modulation of keratin 5 expression and distribution either due to mutations or factors may account for the development of pigmentary disorders.

Keywords: dermis; fibroblasts; hyperpigmentation; keratin 5; keratinocytes; melanocytes; skin substitutes.

MeSH terms

  • Adult
  • Animals
  • Cell Differentiation
  • Cell Proliferation
  • Dermis / metabolism*
  • Epidermis / metabolism*
  • Fibroblast Growth Factor 2 / metabolism
  • Fibroblasts / pathology
  • Heterografts
  • Humans
  • Hyperpigmentation / pathology
  • Keratin-5 / metabolism*
  • Lentigo / pathology
  • Melanins / metabolism
  • Mice, Nude
  • Skin Diseases, Genetic / pathology
  • Skin Diseases, Papulosquamous / pathology
  • Skin Pigmentation
  • White People

Substances

  • Keratin-5
  • Melanins
  • Fibroblast Growth Factor 2

Supplementary concepts

  • Dowling-Degos Disease